Each row is a biotech company with active signals from FDA filings, SEC disclosures, clinical trial databases, and insider trading records. Use the filters below to surface the companies worth researching before the market moves.
A–F letter grade based on the quality and timing of upcoming catalysts — PDUFA dates, AdCom votes, Phase 3 readouts. A = multiple near-term high-impact events. F = nothing on the calendar.
0–100 composite measuring signal density across all data sources. A score of 80+ means multiple independent signals are firing simultaneously — insider buys, clinical activity, and an approaching FDA date, for example.
A scheduled event with a known date that can move a biotech stock significantly — FDA approval decisions (PDUFA), advisory committee votes (AdCom), Phase 2/3 trial data readouts, and earnings.
Tags showing which data sources fired. PDUFA = approval date. Insider Buy = executive bought shares. Convergence = StonkWhisper momentum aligned with fundamentals. Dilution = SEC filing suggests offering risk.
DilutionWatch score (0–100) measuring SEC-filing evidence of upcoming share dilution. CRITICAL = active S-3/ATM shelf, offering likely this quarter. LOW = healthy balance sheet, no shelf detected.
Estimated months of cash remaining at the current burn rate from DilutionWatch. A company cannot survive to its PDUFA date without cash. Under 6 months = likely to raise capital soon.
| Ticker↕ | Company↕ | Sector↕ | Score▼ | Grade↕ | DW Risk↕ | Cash↕ | Signals | Next Catalyst↕ | |
|---|---|---|---|---|---|---|---|---|---|
| AQUA | Aquestive Therapeutics | CNS | 92.63 | A | — | — | — | — | |
| WCG | PharmaLex | Regulatory Consulting | 92.63 | A | — | — | — | — | |
| ARCH | Arctus Therapeutics | Inflammatory | 92.55 | A | — | — | — | — | |
| BIS | Biosign Technologies | Cardiovascular Diagnostics | 92.55 | A | — | — | — | — | |
| BIOS | BioSig Technologies | Cardiac Electrophysiology | 92.32 | A | — | — | — | — | |
| AGIO | Agios Pharmaceuticals | Rare Disease | 91.75 | A | — | — | — | — | |
| ADIL | Adial Pharmaceuticals, Inc | Biotech / Pharma | 91.68 | A | — | — | — | — | |
| ANTE | AntriaBio | Endocrinology | 91.68 | A | — | — | — | — | |
| INVO | INVO Bioscience | Infertility IVF | 91.63 | A | — | — | — | — | |
| EMED | Edgemont Pharmaceuticals | Pediatric CNS | 87.72 | A | — | — | — | — | |
| AIM | AIM ImmunoTech Inc. | Immunology | 85.43 | A | — | — | — | — | |
| CPH | Cipher Pharmaceuticals | Dermatology / Acne | 84.74 | A | — | — | — | — | |
| FEED | ENvue Medical, Inc. | Biotech / Pharma | 84.62 | A | — | — | — | — | |
| BYRN | Byrna Technologies, Inc. | RNA Therapy | 82.69 | A | — | — | — | — | |
| CUB | Lionheart Holdings Class A | Cardiovascular | 82.41 | A | — | — | — | — | |
| SBC | SBC Medical Group Holdings Incorporated | Biotech / Pharma | 82.16 | A | — | — | — | — | |
| GOSS | Gossamer Bio | Immunology/Oncology | 82.15 | A | — | — | — | — | |
| PALI | Palisade Bio, Inc. | Biotech / Pharma | 82.06 | A | — | — | — | — | |
| MGM | MGM Resorts International | RNA Therapy | 81.91 | A | — | — | — | — | |
| DRUG | Bright Minds Biosciences Inc. | Biotech / Pharma | 81.74 | A | — | — | — | — | |
| PBM | Psyence Biomedical Ltd. Common Shares | Biotech / Pharma | 81.72 | A | — | — | — | — | |
| VERV | Verve Therapeutics | Cardiovascular | 81.67 | A | — | — | — | — | |
| IKT | Inhibikase Therapeutics, Inc. | Biotech / Pharma | 81.54 | A | — | — | — | — | |
| HAO | Haoxi Health Technology Limited Class A | Biotech / Pharma | 81.31 | A | — | — | — | — | |
| CUE | Cue Biopharma, Inc. | Biotech / Pharma | 81.16 | A | — | — | — | — | |
| CAMP | CAMP4 Therapeutics Corporation | Biotech / Pharma | 81.07 | A | — | — | — | — | |
| ARDT | Ardent Health, Inc. | Biotech / Pharma | 81.06 | A | — | — | — | — | |
| IMA | ImageneBio, Inc. | Biotech / Pharma | 80.98 | A | — | — | — | — | |
| MAIA | MAIA Biotechnology, Inc. | Biotech / Pharma | 80.89 | A | — | — | — | — | |
| MPT | Medical Properties Trust, Inc. | Biotech / Pharma | 80.85 | A | — | — | — | — | |
| MFI | mF International Limited Class A | RNA Therapy | 80.83 | A | — | — | — | — | |
| BEAT | Heartbeam, Inc. | Cardiovascular | 80.77 | A | — | — | — | — | |
| NCI | Neo-Concept International Group Holdings Limited Class A | RNA Therapy | 80.69 | A | — | — | — | — | |
| LAB | Standard BioTools Inc. | Biotech / Pharma | 80.68 | A | — | — | — | — | |
| MBX | Microbix Biosystems | Viral Antigens Diagnostics | 80.66 | A | — | — | — | — | |
| ATRA | Atara Biotherapeutics | Cell Therapy | 80.63 | A | — | — | — | — | |
| ACH | Accendra Health, Inc. | Biotech / Pharma | 80.51 | A | — | — | — | — | |
| OGEN | Otonomy Inc | Ear Drug Delivery | 80.51 | A | — | — | — | — | |
| ICU | SeaStar Medical Holding Corporation | Biotech / Pharma | 80.44 | A | — | — | — | — | |
| SAVA | Cassava Sciences | Neuroscience | 80.38 | A | — | — | — | — | |
| DH | Definitive Healthcare Corp. | Biotech / Pharma | 80.31 | A | — | — | — | — | |
| CHH | Choice Hotels International, Inc. | RNA Therapy | 80.26 | A | — | — | — | — | |
| INO | Inovio Pharmaceuticals, Inc. | Biotech / Pharma | 80.24 | A | — | — | — | — | |
| AIN | Albany International Corporation | RNA Therapy | 80.21 | A | — | — | — | — | |
| NHI | National Health Investors, Inc. | Biotech / Pharma | 80.03 | A | — | — | — | — | |
| TIL | Instil Bio, Inc. | Biotech / Pharma | 80.03 | A | — | — | — | — | |
| TRT | Trio-Tech International | RNA Therapy | 80.03 | A | — | — | — | — | |
| VANI | Vivani Medical, Inc. | Biotech / Pharma | 79.87 | B | — | — | — | — | |
| GUTS | Fractyl Health, Inc. | Biotech / Pharma | 79.86 | B | — | — | — | — | |
| VNO | Vornado Realty Trust | RNA Therapy | 79.62 | B | — | — | — | — |
Not financial advice. Data by Guerilla Finance Inc. for informational purposes only. Always conduct your own due diligence.